{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ADAG/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T02:34:47.207Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10780,"canonical_name":"Adagene Inc.","cik":"0001818838","uei":null,"lei":null,"duns":null,"ticker":"ADAG"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":17},"count":17,"timeline":[{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Adagene Inc. — 2026-10-02","url_slug":"/sec/cik-0001818838/4/0001104659-26-113397","accession_number":"0001104659-26-113397","importance":30},{"ts":"2026-09-25","kind":"sec.filing","form_type":"4","title":"4 — Adagene Inc. — 2026-09-25","url_slug":"/sec/cik-0001818838/4/0001104659-26-111069","accession_number":"0001104659-26-111069","importance":30},{"ts":"2026-09-25","kind":"sec.filing","form_type":"6-K","title":"6-K — Adagene Inc. — 2026-09-25","url_slug":"/sec/cik-0001818838/6-k/0001104659-26-110982","accession_number":"0001104659-26-110982","importance":30},{"ts":"2026-09-23","kind":"sec.insider.2000","reporter":"Tam Man Kin","title":"Chief Financial Officer","shares":2000,"price_per_share":3,"usd_value":6000,"security_title":"American Depositary Shares (ADSs)","importance":15.006},{"ts":"2026-09-22","kind":"sec.filing","form_type":"6-K","title":"6-K — Adagene Inc. — 2026-09-22","url_slug":"/sec/cik-0001818838/6-k/0001104659-26-109485","accession_number":"0001104659-26-109485","importance":30},{"ts":"2026-09-17","kind":"sec.filing","form_type":"4","title":"4 — Adagene Inc. — 2026-09-17","url_slug":"/sec/cik-0001818838/4/0001104659-26-108386","accession_number":"0001104659-26-108386","importance":30},{"ts":"2026-09-10","kind":"sec.filing","form_type":"6-K","title":"6-K — Adagene Inc. — 2026-09-10","url_slug":"/sec/cik-0001818838/6-k/0001104659-26-106554","accession_number":"0001104659-26-106554","importance":30},{"ts":"2026-09-09","kind":"sec.filing","form_type":"6-K","title":"6-K — Adagene Inc. — 2026-09-09","url_slug":"/sec/cik-0001818838/6-k/0001104659-26-106137","accession_number":"0001104659-26-106137","importance":30},{"ts":"2026-08-20","kind":"sec.filing","form_type":"144/A","title":"144/A — Adagene Inc. — 2026-08-20","url_slug":"/sec/cik-0001818838/144-a/0001104659-26-099289","accession_number":"0001104659-26-099289","importance":30},{"ts":"2026-08-19","kind":"sec.filing","form_type":"144","title":"144 — Adagene Inc. — 2026-08-19","url_slug":"/sec/cik-0001818838/144/0002108105-26-000001","accession_number":"0002108105-26-000001","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"4","title":"4 — Adagene Inc. — 2026-08-17","url_slug":"/sec/cik-0001818838/4/0001104659-26-097995","accession_number":"0001104659-26-097995","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"4","title":"4 — Adagene Inc. — 2026-08-17","url_slug":"/sec/cik-0001818838/4/0001104659-26-097996","accession_number":"0001104659-26-097996","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"4","title":"4 — Adagene Inc. — 2026-08-14","url_slug":"/sec/cik-0001818838/4/0002120696-26-000002","accession_number":"0002120696-26-000002","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"6-K","title":"6-K — Adagene Inc. — 2026-08-12","url_slug":"/sec/cik-0001818838/6-k/0001104659-26-094468","accession_number":"0001104659-26-094468","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"4","title":"4 — Adagene Inc. — 2026-08-06","url_slug":"/sec/cik-0001818838/4/0001104659-26-092176","accession_number":"0001104659-26-092176","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"6-K","title":"6-K — Adagene Inc. — 2026-07-06","url_slug":"/sec/cik-0001818838/6-k/0001104659-26-080580","accession_number":"0001104659-26-080580","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"SCHEDULE 13D/A","title":"SCHEDULE 13D/A — Adagene Inc. — 2026-06-08","url_slug":"/sec/cik-0001818838/schedule-13d-a/0001104659-26-071145","accession_number":"0001104659-26-071145","importance":70}]}